– Reuters
DuPont Plans To Sell Its Delrin Resins Business For $1.8B: Report
DuPont de Nemours Inc (NYSE: DD) is reportedly in advance talks with The Jordan Company to sell its chemical assets, Delrin resins unit, for around $1.8 billion.
Related Posts
AstraZeneca – Daiichi Sankyo’s Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
The European Commission has approved AstraZeneca Plc (NASDAQ:AZN) – Daiichi Sankyo’s (OTC:DSKYF) (OTC:DSNKY) Enhertu (trastuzumab deruxtecan) for advanced HER2-positive gastric or gastroesophageal junction…
Citigroup Assumes Range Resources at Neutral, Announces Price Target of $31
Citigroup analyst Paul Diamond assumes Range Resources (NYSE:RRC) with a Neutral rating and announces Price Target of $31.
Cannabis MSOs Are Refinancing At Higher Costs, Check Their Balance Sheets Analyst Advises
Even top multi-state operators (MSOs) are feeling the impact of the demand and supply capital imbalance faced by the cannabis industry, says Cantor Fitzgerald's Pablo Zuanic who noted that refinancings are being undertaken at higher than normal costs.